You are not currently logged in.
Access JSTOR through your library or other institution:
Clinical Outcomes of Estonian Patients with Primary Multidrug-Resistant versus Drug-Susceptible Tuberculosis
Shahin Lockman, Annika Kruuner, Nancy J. Binkin, Klaudia Levina, Yong Chang Wang, Manfred Danilovitsh, Sven E. Hoffner and Jordan W. Tappero
Clinical Infectious Diseases
Vol. 32, No. 3 (Feb. 1, 2001), pp. 373-380
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4482486
Page Count: 8
You can always find the topics here!Topics: Tuberculosis, Mycobacterium tuberculosis, Multidrug resistant tuberculosis, Health outcomes, Pulmonary tuberculosis, Medical treatment failures, Disease outbreaks, Preventive medicine, Sputum, Disease transmission
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Little is known about the clinical outcomes of patients with primary multidrug-resistant (MDR) tuberculosis. Clinical outcomes among 46 patients in Estonia with primary MDR tuberculosis and 46 patients with pansusceptible tuberculosis were compared. Patients with MDR tuberculosis were more likely than those with pansensitive tuberculosis to have treatment failure (odds ratio, 8.9; 95% confidence interval [CI], 3.0-26.3) after adjusting for medical problems and weeks of effective treatment, often with second-line drugs. Ten patients (22%) with MDR tuberculosis and 2 (4%) with susceptible tuberculosis died of tuberculosis (P = .03). MDR tuberculosis (hazard ratio [HR], 7.8; 95% CI, 1.6-37.4), number of medical problems (HR, 2.5; 95% CI, 1.5-4.4), and male sex (HR, 5.8; 95% CI, 1.1-29.6) were associated with death due to tuberculosis in multivariable analysis. Human immunodeficiency virus test results were negative for all 55 patients tested. These findings underscore the urgent need for increased attention to prevention and treatment of MDR tuberculosis globally.
Clinical Infectious Diseases © 2001 Oxford University Press